+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients

Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients

Journal of Hospital Infection 78(1): 54-58

Ertapenem-resistant Klebsiella pneumoniae (ER-Kp) is an emerging healthcare-associated pathogen. In order to identify risk factors associated with ER-Kp acquisition, the records of 100 patients from whom K. pneumoniae had been isolated between July 2008 and December 2009 were reviewed. These comprised 38 with ER-Kp (28 infected, 10 colonised) and 62 with ertapenem-susceptible K. pneumoniae (ES-Kp) (43 infected, 19 colonised). Multilocus sequence typing (MSLT) and porin gene investigation performed on 25 ER-Kp strains showed that 24 belonged to the ST37 lineage, expressing a novel OmpK36 variant and not expressing OmpK35. Breakthrough bacteraemia occurred in 13 (52%) of 25 bloodstream infections (BSIs). Among nine ER-Kp BSIs, five were complicated by breakthrough bacteraemia, of which four developed during carbapenem therapy. Among 16 ES-Kp BSIs, breakthrough bacteraemia developed in eight patients (50%), but only one occurred (12%) during carbapenem therapy. Logistic regression analysis showed that carbapenems (odds ratio: 12.9; 95% confidence interval: 3.09-53.7; P < 0.001), second generation cephalosporins (11.8; 1.87-74.4; P < 0.01), endoscopy (5.59; 1.32-23.6; P < 0.02), acute renal failure (5.32; 1.13-25.1; P=0.034) and third generation cephalosporins (4.15; 1.09-15.8; P < 0.01) were independent risk factors for acquisition of ER-Kp. Our findings confirm that prior use of certain antimicrobials, specifically carbapenems and cephalosporins, are primary independent risk factors for colonisation or infection with ER-Kp.

(PDF emailed within 0-6 h: $19.90)

Accession: 055579035

Download citation: RISBibTeXText

PMID: 21450365

DOI: 10.1016/j.jhin.2011.01.014

Related references

Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. American Journal of Infection Control 40(5): 421-425, 2012

Nosocomial infection of hospitalised patients with chemotherapy-resistant strains of Klebsiella pneumoniae. Deutsche Medizinische Wochenschrift 103(41): 1593-1597, 1978

Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. Journal of Hospital Infection 74(4): 344-349, 2010

Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microbial Drug Resistance 11(2): 165-169, 2005

A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients. Journal of Infection in Developing Countries 10(3): 208-213, 2016

Risk factors for outbreaks of multidrug-resistant Klebsiella pneumoniae in critical burn patients. Journal of Burn Care & Research 33(3): 386-392, 2012

Community-onset bacteraemia caused by fluoroquinolone-resistant Klebsiella pneumoniae: clinical epidemiology and risk factors. International Journal of Antimicrobial Agents 39(2): 181-182, 2012

Risk factors for the first episode of Klebsiella pneumoniae resistant to carbapenems infection in critically ill patients: a prospective study. Biomed Research International 2013(): 850547-850547, 2014

Prevalence and characteristics of ertapenem-resistant Klebsiella pneumoniae isolates in a Taiwanese university hospital. Microbial Drug Resistance 17(2): 259-266, 2011

Rapid ertapenem susceptibility testing and Klebsiella pneumoniae carbapenemase phenotype detection in Klebsiella pneumoniae isolates by use of automated microscopy of immobilized live bacterial cells. Journal of Clinical Microbiology 52(3): 982-986, 2014

A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. Bmc Infectious Diseases 13: 80-80, 2013

Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia. Journal of Antimicrobial ChemoTherapy 68(12): 2907-2914, 2014

Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes. Clinical Microbiology and Infection 12(1): 63-68, 2006

Comparison of ertapenem-EMB Agar with traditional methods for screening carbapenem-resistant Klebsiella pneumoniae from rectal swabs. Mikrobiyoloji Bulteni 46(4): 546-552, 2014